Rallybio CORP Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
Venture capital firm 5AM Ventures has disclosed the sale of approximately 291,788 shares of Rallybio Corp common stock.
NASDAQ
5AM Ventures and its affiliates have filed an Amendment No. 2 to their Schedule 13D, reporting a reduction in their beneficial ownership of Rallybio Corp common stock following recent open market sales.